: Endobiliary radiofrequency ablation (RFA) is a new endoscopic ablative technique. However, the ideal power setting for RFA has not yet been clarified. Therefore, we intended to evaluate the effects of endobiliary RFA according to time variations using novel RFA. : Nine female pigs were divided into three groups according to ablation time (60, 90, and 120 seconds) with the same setting (10 watts, 80 °C). All pigs underwent endoscopic retrograde cholangiography (ERC) and endobiliary RFA in the common bile duct. Gross and histologic examinations were performed after 24 hours. Results: The ERC and application of the endobiliary RFA were 100% successful, and the post-RFA cholangiogram did not show contrast leakage. The median depth of microscopic ablation was significantly different among the three groups (60 vs. 90 vs. 120 seconds = 1.90 (1.17-2.23) vs. 2.44 (2.31-2.60) vs. 2.52 (2.47-2.64) mm,  = 0.018). There was also a linear relationship between ablation time and microscopic ablation depth ( = 0.552,  = 0.002). However, no significant differences in macroscopic or microscopic ablation length were observed. In addition, there were focal ablation injuries in adjacent liver tissue in five of the nine pigs (2/3 in 60, 1/3 in 90, and 2/3 in 120 seconds). : Endobiliary RFA using a novel RFA catheter resulted in controlled ablation with a linear relationship between microscopic ablation depth and ablation time in a swine model. Clinical studies are needed to validate the safe energy condition of endobiliary RFA in malignant biliary obstruction.

Download full-text PDF

Source
http://dx.doi.org/10.1080/08941939.2018.1489566DOI Listing

Publication Analysis

Top Keywords

endobiliary rfa
20
microscopic ablation
16
ablation
12
radiofrequency ablation
12
ablation time
12
rfa
9
endobiliary radiofrequency
8
swine model
8
novel rfa
8
three groups
8

Similar Publications

Percutaneous transhepatic cholangiography: An effective option for endo-biliary radiofrequency ablation before stent insertion in unresectable biliary cancer?

World J Clin Cases

October 2024

Academic Department of Gastroenterology, Medical School of the National and Kapodistrian University of Athens, "Laiko" General Hospital, Athens 11527, Greece.

Biliary cancer is a highly aggressive disease that is typically diagnosed at advanced stages when surgical removal is no longer an option. In these cases, palliative care and mechanical widening of the blocked biliary system are preferred. The insertion of a stent is often necessary to prevent the recurrence of blockages caused by cancer progression.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated the safety and effectiveness of percutaneous endobiliary radiofrequency ablation (EB-RFA) for treating stubborn benign biliary strictures in 15 patients who had unsuccessful traditional treatments.
  • Results showed a 100% technical success rate and an 87% clinical success rate after a median follow-up of 17 months, indicating significant improvement in patients’ conditions.
  • The findings suggest that EB-RFA is a promising option for these strictures, though more extensive studies are needed for more conclusive evidence.
View Article and Find Full Text PDF

Introduction: The role of endo-biliary radio-frequency ablation (EB-RFA) in treating malignant biliary strictures remains a subject of controversy. This study aims to assess the efficacy and safety of EB-RFA in conjunction with self-expandable metal stents (SEMS) compared to SEMS alone.

Methods: This single-center prospective pragmatic comparative study, conducted between June 2021 and November 2022, involved 23 patients undergoing EB-RFA plus SEMS and 48 patients undergoing SEMS for unresectable malignant hilar obstruction.

View Article and Find Full Text PDF

Percutaneous endobiliary radiofrequency ablation and stent placement for unresectable malignant biliary obstruction: a propensity score matching retrospective study.

BMC Gastroenterol

August 2024

Department of Interventional Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, No. 106 Zhongshan 2nd Road, Guangzhou, 510080, China.

Background: Whether endobiliary radiofrequency ablation (EB-RFA) changes the standard role of stent placement in treating unresectable malignant biliary obstruction (MBO) remains unclear. The aim of this study is to compare percutaneous EB-RFA and metal stent placement (RFA-Stent) with metal stent placement alone (Stent) in treating unresectable MBO using a propensity score matching (PSM) analysis.

Methods: From June 2013 to June 2018, clinical data from 163 patients with malignant biliary obstruction who underwent percutaneous RFA-Stent or stenting alone were retrospectively analyzed using a nearest-neighbor algorithm to one-to-one PSM analysis to compare primary and secondary stent patency (PSP, SSP), overall survival (OS) and complications between the two groups.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on the safety and effectiveness of combining endobiliary radiofrequency ablation (EB-RFA) with percutaneous transhepatic cholangiodrainage (PTCD) for managing patients with unresectable malignant obstructive jaundice.
  • Results showed significant decreases in the total and direct bilirubin levels within a week post-procedure, indicating improved jaundice control, although other liver function markers showed no significant changes.
  • Complications were minimal, with some patients experiencing biliary bleeding and pancreatitis, but there were no serious complications or deaths, leading to a median survival of 4 months for the patients involved.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!